Literature DB >> 1442465

Adverse psychiatric effects of systemic glucocorticoid therapy.

J F Klein1.   

Abstract

Glucocorticoid therapy causes psychiatric side effects in many patients. Although psychiatric side effects occur most commonly in women and middle-aged patients, no clinical features have been identified to predict which patients are at risk. The most frequent side effects are mood changes ranging from mild euphoria to hypomania, but other reactions, including depression, dementia and psychosis, are possible. The incidence of psychiatric side effects is directly related to dosage. The mechanism by which glucocorticoids produce psychiatric symptoms is probably multifactorial, including both direct and indirect effects on the brain. Psychiatric symptoms usually resolve with dosage reduction or controlled withdrawal of glucocorticoids, but antipsychotic medication may be indicated if symptoms are severe or prolonged.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1442465

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  9 in total

Review 1.  Management of secondary-progressive multiple sclerosis.

Authors:  Gavin Giovannoni
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

3.  Psychotic reaction as a manifestation of multiple sclerosis relapse treated with plasma exchange.

Authors:  Tereza Gabelić; Ivan Adamec; Anamarija Mrđen; Milan Radoš; Vesna V Brinar; Mario Habek
Journal:  Neurol Sci       Date:  2011-07-28       Impact factor: 3.307

4.  [Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].

Authors:  C Laske; T Leyhe; G Buchkremer; H Wormstall
Journal:  Nervenarzt       Date:  2005-05       Impact factor: 1.214

Review 5.  Clinical experience with repository corticotropin injection in patients with multiple sclerosis experiencing mood changes with intravenous methylprednisolone: a case series.

Authors:  Stacey Murray; Andrew Woo
Journal:  Ther Adv Neurol Disord       Date:  2015-12-07       Impact factor: 6.570

6.  Differential diagnosis of steroid-dependent nephrotic syndrome with psychosis: Practical and ethical issues.

Authors:  C K Westergaard; C J Nowinski; J J Sweet
Journal:  J Clin Psychol Med Settings       Date:  1996-03

7.  Anxiety and depression in patients with rheumatoid arthritis.

Authors:  Ahmet Isik; Suleyman Serdar Koca; Abdullah Ozturk; Osman Mermi
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 3.650

8.  Addiction and the adrenal cortex.

Authors:  Gavin P Vinson; Caroline H Brennan
Journal:  Endocr Connect       Date:  2013-05-31       Impact factor: 3.335

9.  Beyond the heterodimer model for mineralocorticoid and glucocorticoid receptor interactions in nuclei and at DNA.

Authors:  John R Pooley; Caroline A Rivers; Michael T Kilcooley; Susana N Paul; Ayse Derya Cavga; Yvonne M Kershaw; Serena Muratcioglu; Attila Gursoy; Ozlem Keskin; Stafford L Lightman
Journal:  PLoS One       Date:  2020-01-10       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.